Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by doubleLson Feb 01, 2019 10:43am
63 Views
Post# 29305469

Tetra Bio Pharma - the hidden gem

Tetra Bio Pharma - the hidden gemI think the company more focused on Pharma & science & drug development will be the successful bidder. Aphria owns roughly 20% of tmTBP and the buyer will have a major ROI when the DIN# and other pipeline products come to life. Makes me think Chronos or Tilray are the likely final suitors. Let the bidding begin though!
Bullboard Posts